Relmada Therapeutics Statistics
Total Valuation
RLMD has a market cap or net worth of $120.70 million. The enterprise value is $24.37 million.
| Market Cap | 120.70M |
| Enterprise Value | 24.37M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RLMD has 30.17 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Shares Outstanding | 30.17M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.24% |
| Owned by Institutions (%) | 46.36% |
| Float | 25.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.41 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.00, with zero debt.
| Current Ratio | 8.00 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.40% and return on invested capital (ROIC) is -121.49%.
| Return on Equity (ROE) | -93.40% |
| Return on Assets (ROA) | -85.10% |
| Return on Capital (ROIC) | -121.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.94M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.35% in the last 52 weeks. The beta is 0.19, so RLMD's price volatility has been lower than the market average.
| Beta (1Y) | 0.19 |
| 52-Week Price Change | +42.35% |
| 50-Day Moving Average | 5.27 |
| 200-Day Moving Average | 3.66 |
| Relative Strength Index (RSI) | 35.01 |
| Average Volume (30 Days) | 214,237 |
Short Selling Information
The latest short interest is 1.69 million, so 5.62% of the outstanding shares have been sold short.
| Short Interest | 1.69M |
| Short Previous Month | 1.75M |
| Short % of Shares Out | 5.62% |
| Short % of Float | 6.62% |
| Short Ratio (days to cover) | 7.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -103.70M |
| Pretax Income | -98.79M |
| Net Income | -98.79M |
| EBITDA | -98.79M |
| EBIT | -98.79M |
| Earnings Per Share (EPS) | -$3.28 |
Balance Sheet
The company has $96.32 million in cash and no debt, giving a net cash position of $96.32 million or $3.19 per share.
| Cash & Cash Equivalents | 96.32M |
| Total Debt | n/a |
| Net Cash | 96.32M |
| Net Cash Per Share | $3.19 |
| Equity / Book Value | 85.36M |
| Book Value Per Share | 2.83 |
| Working Capital | 85.31M |
Cash Flow
| Operating Cash Flow | -51.66M |
| Capital Expenditures | n/a |
| Free Cash Flow | -51.66M |
| FCF Per Share | -$1.72 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.59% |
| Shareholder Yield | -1.59% |
| Earnings Yield | -81.85% |
| FCF Yield | -42.80% |
Analyst Forecast
The average price target for RLMD is $26.00, which is 550.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.00 |
| Price Target Difference | 550.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.
| Last Split Date | Sep 30, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |